Press Release Archive
Press Releases
March 2020
03.13.2020 Covid-19 Vaccines Pfizer Outlines Five-Point Plan to Battle COVID-19 03.13.2020 Research EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study 03.04.2020 Leadership Susan Hockfield Elected to Pfizer’s Board of Directors 03.02.2020 Covid-19 Vaccines Pfizer Provides Comment on COVID-19 White House Meeting 03.02.2020 Medicines U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis
February 2020
02.27.2020 Leadership James Quincey Elected to Pfizer’s Board of Directors 02.27.2020 Finance Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer 02.27.2020 Finance Mylan and Pfizer Finalize Appointments to Viatris Board of Directors 02.27.2020 Finance Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer 02.27.2020 Finance Mylan and Pfizer Finalize Appointments to Viatris Board of Directors 02.25.2020 Finance Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 02.20.2020 Partnerships Montis Biosciences launched with €8,4 million seed financing and a novel approach to immune-oncology
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.